SAN FRANCISCO, CA — November 6, 2025 — Leads & Copy — Channel Medsystems, a women’s health company, announced that over 5,000 women have been treated with the Cerene® Cryotherapy Device. The device is an innovative solution for heavy menstrual bleeding (HMB) and dysmenorrhea.
The FDA-approved Cerene device is designed for use in a gynecologist’s office without general anesthesia or operating-room resources. According to the company, the milestone reflects the device’s expanding adoption across hospitals, ambulatory surgery centers, and private OB/GYN practices.
Paul Russo, Vice President of Sales at Channel Medsystems, stated that the number of cases demonstrates the device’s integral role in the modern gynecologist’s toolkit. He noted that physicians appreciate the device’s ease of use, patients appreciate the comfort and safety, and health systems appreciate the efficiency and economics of an in-office treatment that delivers long-term relief.
The company reports that the 5,000-procedure milestone follows a period of accelerated momentum, with the company expanding its national footprint through commercial team growth, strategic partnerships, physician education programs, and growing payer coverage. The company is focused on advancing cryotherapy as a new standard of care in heavy menstrual bleeding, supporting its mission to empower every woman to take control of her health journey.
Nelson Whistance, President and CEO of Channel Medsystems, stated that each Cerene procedure represents a woman choosing to address heavy bleeding and dysmenorrhea in a way that fits her life, validating both the clinical impact of cryotherapy and the dedication of the company’s growing network of providers who are redefining care for women everywhere.
Channel Medsystems is a privately held company that is dedicated to transforming women’s healthcare through the development and commercialization of the Cerene® Cryotherapy Device, a non-hormonal, incision-free treatment designed to provide safe, effective, and convenient therapy for women suffering from HMB and dysmenorrhea.
Offering a modern alternative to invasive surgery or long-term medications, Channel Medsystems is committed to improving patient outcomes, broadening access, and empowering women with greater control over their care.
Tara Murphy
Vice President, Marketing
Channel Medsystems
tmurphy@cerene.com
215-620-3004
Source: Channel Medsystems
